Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2013 3
2014 2
2015 4
2016 4
2017 3
2018 2
2019 4
2020 4
2021 8
2022 8
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis.
Venken K, Jarlborg M, Decruy T, Mortier C, Vlieghe C, Gilis E, De Craemer AS, Coudenys J, Cambré I, Fleury D, Klimowicz A, Van den Bosch F, Hoorens A, Lobaton T, de Roock S, Sparwasser T, Nabozny G, Jacques P, Elewaut D. Venken K, et al. Among authors: de roock s. Ann Rheum Dis. 2023 Aug;82(8):1076-1090. doi: 10.1136/ard-2022-223757. Epub 2023 May 17. Ann Rheum Dis. 2023. PMID: 37197892
The human microbiome and juvenile idiopathic arthritis.
Verwoerd A, Ter Haar NM, de Roock S, Vastert SJ, Bogaert D. Verwoerd A, et al. Among authors: de roock s. Pediatr Rheumatol Online J. 2016 Sep 20;14(1):55. doi: 10.1186/s12969-016-0114-4. Pediatr Rheumatol Online J. 2016. PMID: 27650128 Free PMC article. Review.
Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry.
van Straalen JW, de Roock S, Giancane G, Alexeeva E, Koskova E, Mesa-Del-Castillo Bermejo P, Zulian F, Civino A, Montin D, Wulffraat NM, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO). van Straalen JW, et al. Among authors: de roock s. Pediatr Rheumatol Online J. 2022 Nov 18;20(1):103. doi: 10.1186/s12969-022-00762-y. Pediatr Rheumatol Online J. 2022. PMID: 36401230 Free PMC article. Review.
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN Variants.
Erkens RGA, Calis JJA, Verwoerd A, De Roock S, Ter Haar NM, Den Engelsman G, Van der Veken LT, Ernst RF, Van Deutekom HWM, Pickering A, Scholman RC, Jansen MHA, Swart JF, Sinha R, Roth J, Schulert GS, Grom AA, Van Loosdregt J, Vastert SJ. Erkens RGA, et al. Among authors: de roock s. Arthritis Rheumatol. 2024 Jan;76(1):119-129. doi: 10.1002/art.42656. Epub 2023 Nov 6. Arthritis Rheumatol. 2024. PMID: 37471469
Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity.
Baars MJD, Douma T, Simeonov DR, Myers DR, Kulhanek K, Banerjee S, Zwakenberg S, Baltissen MP, Amini M, de Roock S, van Wijk F, Vermeulen M, Marson A, Roose JP, Vercoulen Y. Baars MJD, et al. Among authors: de roock s. Eur J Immunol. 2021 Feb;51(2):471-482. doi: 10.1002/eji.201948451. Epub 2020 Nov 16. Eur J Immunol. 2021. PMID: 33065764 Free PMC article.
49 results